Investor Relations News Releases January 3, 2023 Histogen Hires Alfred P. Spada Ph.D. as Executive Vice President and Chief Scientific Officer November 10, 2022 Histogen Reports Third Quarter 2022 Financial Results and Provides Business Update View All Events More events are coming soon. View All SEC Filings Filing date Form Jan 03, 2023 8-K Dec 02, 2022 8-K View All
January 3, 2023 Histogen Hires Alfred P. Spada Ph.D. as Executive Vice President and Chief Scientific Officer
